Web Date: January 11, 2016
Thermo Fisher To Buy Affymetrix For $1.3 Billion
Thermo Fisher Scientific has reached a deal to buy gene-sequencing expert Affymetrix for $1.3 billion. The $14.00-per-share price is about 50% above Affymetrix’s share price after the stock market closed on Jan. 8.
Although not as large as Thermo Fisher’s $13.6 billion acquisition of Life Technologies in 2014, this latest acquisition further cements the firm’s role as a supplier of equipment and consumables to the . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society